Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Antibodies, Blocking MeSH Descriptor Data 2026


MeSH Heading
Antibodies, Blocking
Tree Number(s)
D12.776.124.486.485.114.143
D12.776.124.790.651.114.143
D12.776.377.715.548.114.143
Unique ID
D019138
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D019138
Annotation
antibodies inhibiting reaction between antigen and other antibodies or sensitized T-lymphocytes: not for any antibody reaction to an antigen ( = ANTIBODIES or specific antibody); do not coordinate with ANTIBODY FORMATION for /‌biosyn
Scope Note
Antibodies that inhibit the reaction between ANTIGEN and other antibodies or sensitized T-LYMPHOCYTES (e.g., antibodies of the IMMUNOGLOBULIN G class that compete with IGE antibodies for antigen, thereby blocking an allergic response). Blocking antibodies that bind tumors and prevent destruction of tumor cells by CYTOTOXIC T-LYMPHOCYTES have also been called enhancing antibodies. (Rosen et al., Dictionary of Immunology, 1989)
Entry Term(s)
Antibodies, Enhancing
Blocking Antibodies
Enhancing Antibodies
Pharm Action
Immunologic Factors
Registry Numbers
0
Public MeSH Note
96
History Note
96
Date Introduced
1996/01/01
Last Updated
2005/06/30
Antibodies, Blocking Preferred
Enhancing Antibodies Narrower
page delivered in 0.162s